埃及导尿管相关尿路感染革兰阴性菌耐药表型与基因型不一致
该研究对埃及曼苏拉某医院132株导尿管相关尿路感染(CAUTI)革兰阴性菌进行表型耐药检测和全基因组测序,发现22株多重耐药、62株广泛耐药,表型与基因型总一致率在ResFinder、CARD和AMRFinder分别为91%、85.7%和80.5%,提示耐药组研究需综合方法。
要点
- CAUTI革兰阴性菌中广泛耐药株占近半(62/132),多重耐药株22/132。
- 表型-基因型不一致常见,ResFinder一致率91%,CARD 85.7%,AMRFinder 80.5%。
- 假单胞菌属种水平及美罗培南药物水平不一致最大,埃及发现新AMR变异。
核心结论
- CAUTI分离株存在耐药表型与基因型不一致,耐药组研究需综合方法。
- 革兰阴性尿路病原体基因组多样性贡献疾病负担,尤其在研究较少的LMIC环境。
研究设计与样本
- 对埃及曼苏拉某医院CAUTI患者分离的132株革兰阴性菌进行表型AMR检测和全基因组测序。
- 使用ResFinder、CARD和AMRFinder预测耐药组,sourmash分析基因组相似性,Panaroo对大肠埃希菌进行泛基因组分析。
主要发现
- 鉴定出67株大肠埃希菌(B2群53.7%,36/67)、14株铜绿假单胞菌、11株肺炎克雷伯菌、9株奇异变形杆菌、8株普罗威登斯菌属、5株霍氏肠杆菌和18株罕见CAUTI相关分离株。
- 22/132株为多重耐药,62/132株为广泛耐药。
- 表型-基因型总一致率:ResFinder 91%(1115/1225)、CARD 85.7%(1273/1485)、AMRFinder 80.5%(1196/1485)。
- 假单胞菌属种水平不一致最大,美罗培南药物水平不一致最大。
- 埃及新发现AMR变异:假单胞菌blaOXA-486、blaOXA-488、blaOXA-905、blaIMP-43、blaPDC-35、blaPDC-45、blaPDC-201;大肠埃希菌blaTEM-176、blaTEM-190。
临床怎么用
- 对CAUTI革兰阴性菌进行耐药检测时,应认识到表型与基因型可能不一致,需综合评估。
- 在埃及等LMIC设置中,耐药组研究应结合多种预测工具并谨慎解读结果。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVES: Catheter-associated urinary tract infections (CAUTIs) are among the most common healthcare-associated infections in low- and middle-income countries (LMICs), but there are few resistome data available for relevant uropathogens. The goal of this study was to characterize the antimicrobial resistance (AMR) phenotypes and genotypes of a large collection of Gram-negative bacteria recovered from CAUTIs in a hospital in Mansoura, Egypt. METHODS: Phenotypic AMR profiles and whole-genome sequence data were generated for 132 isolates. Resistomes were predicted using ResFinder, CARD and AMRFinder. Similarity of uropathogen genomic data was determined using sourmash (kmer signatures). Escherichia coli genomic data were subject to a pangenome analysis using Panaroo. RESULTS: Sixty-seven E. coli (Phylogroup B2; 53.7%, 36/67), 14 Pseudomonas aeruginosa, 11 Klebsiella pneumoniae, 9 Proteus mirabilis, 8 Providencia spp., 5 Enterobacter hormaechei and 18 rare CAUTI-associated isolates were identified. Several (22/132) isolates were multidrug-resistant, while almost half (62/132) were extensively drug-resistant. Phenotype-genotype discordance was found to be an important consideration in resistome studies in Egypt, with a total concordance of 91% (1115/1225), 85.7% (1273/1485) and 80.5% (1196/1485) for ResFinder, CARD and AMRFinder, respectively. Pseudomonas, at the species level, exhibited the greatest discordance. At the antimicrobial level, meropenem was subject to greatest discordance. New AMR variants were found for Egypt for Pseudomonas (blaOXA-486, blaOXA-488, blaOXA-905, blaIMP-43, blaPDC-35, blaPDC-45, blaPDC-201) and E. coli (blaTEM-176, blaTEM-190). CONCLUSIONS: This study shows that there is phenotype-genotype discordance in AMR profiling among CAUTI isolates, highlighting the need for comprehensive approaches in resistome studies. We also show the genomic diversity of Gram-negative uropathogens contributing to disease burden in a little-studied LMIC setting.
引用
- Eladawy M, Heslop N, Negus D, et al. Phenotype-genotype discordance in antimicrobial resistance profiles of Gram-negative uropathogens recovered from catheter-associated urinary tract infections in Egypt. J Antimicrob Chemother. 2025. PMID: 40985147. doi:10.1093/jac/dkaf352
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。